Antibiotics can be used to treat a litany of illnesses, but one thing they can’t combat is a viral infection.
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results